Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00248027
Other study ID # REB #04-203
Secondary ID
Status Terminated
Phase Phase 1
First received November 1, 2005
Last updated September 12, 2006
Start date January 2004

Study information

Verified date September 2006
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

Main Research questions:

1. Who are the patients referred for treatment at the Psychotic Disorders Clinic?

2. What are the outcomes from treatment for first episode psychosis in multiple outcome domains?

3. What hospital resources are used over the early course of the illness?

4. How satisfied are patients and family with the treatment and services they received? This is an important study that will help us evaluate the service and treatment offered by the Psychotic Disorders Clinic's specialized early intervention program,which helps young people experiencing early stages of psychotic illness.A growing body of evidence suggests that intervening earlier in the course of the illness with specialized and complimentary pharmacological and psychosocial treatment may be associated with improved outcomes.


Description:

The project is primarily a descriptive study of individuals experiencing their first episode of psychosis presenting at the Psychotic Disorders Clinic/Early Intervention Program.

The objectives of the study are:

1. Track multi-dimensional outcomes within the program

2. Track service use

3. Compare outcomes for this early intervention program with outcomes noted in published follow up studies

4. Evaluate effectiveness of the Psychotic Disorders Clinic in improving outcomes for persons experiencing their first episode of psychosis


Recruitment information / eligibility

Status Terminated
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 16 Years to 50 Years
Eligibility Inclusion Criteria:

- male or female between ages of 16 to 50 years of age

- capable of providing informed consent

- receiving treatment voluntarily

- experiencing a "first episode of psychosis" defined as the first episode of illness and where the subject,at presentation,meets DSM-IV criteria for one of the following diagnoses:schizophrenia,schizophreniform disorder,schizoaffective disorder,brief psychotic disorder,delusional disorder,and psychosis NOS

Exclusion Criteria:

- primary diagnosis of mood disorder

- diagnosis of substance-induced psychosis

- diagnosis of psychosis due to a general medical condition

- diagnosis of mental retardation

- diagnosis of developmental disorder

- has received antipsychotic treatment for greater than 1 month

- has received treatment for an earlier episode of psychosis from which there has been a remission of symptoms for greater than 3 months

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Cleghorn Program-Early Intervention in Psychosis.St Joseph's Healthcare Hamilton/Hamilton Health Sciences Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
Hamilton Health Sciences Corporation

Country where clinical trial is conducted

Canada,